089140 — NexturnBioScience Co Balance Sheet

0.000.00%

Last trade - 00:00

IndustrialsHighly SpeculativeMicro CapSucker Stock

Market Cap
KR₩36bn
Enterprise Value
KR₩81bn
Revenue
KR₩32bn

Annual balance sheet for NexturnBioScience Co, fiscal year end - December 31st, KRW millions except per share, conversion factor applied.

	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st
Period Length:	—	—	—	—	—
Source:	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts
Standards:	IFRS	IFRS	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final	Final
Cash
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	53,801	41,184	28,147	31,141	35,863
Net Total Accounts Receivable
Net Total Receivables	5,970	4,327	8,647	8,807	8,713
Total Inventory
Prepaid Expenses
Total Other Current Assets
Total Current Assets	66,786	50,946	43,966	46,777	53,107
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	16,043	12,662	28,628	27,955	27,227
Net Goodwill
Net Intangible Assets
Long Term Investments
Long Term Notes Receivable
Other Long Term Assets
Total Assets	99,351	138,949	200,257	243,994	233,037
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	2,069	43,218	19,702	93,672	22,833
Long Term Debt
Capital Lease Obligations
Total Long Term Debt
Total Debt
Deferred Income Tax
Minority Interest
Total Other Liabilities
Total Funded Status
Total Liabilities	2,583	46,214	91,983	105,981	96,413
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Treasury Stock
Unrealized Gain / Loss
Other Equity
Total Equity	96,768	92,735	108,274	138,014	136,624
Total Liabilities & Shareholders' Equity	99,351	138,949	200,257	243,994	233,037
Total Common Shares Outstanding